The Genetic Basis of Aggressive Prostate Cancer, The Role of Rare Variation

AFFECTION_STATUS - Case or control status of the subject (phv00494213.v1.p2)
BIOCHEMICAL_RECURRENCE - Biochemical recurrence (phv00529815.v1.p2)
DEATH_PC - Death from prostate cancer (phv00396696.v2.p2)
FH_PROS - Family history: First degree relative diagnosed with prostate cancer (phv00396695.v2.p2)
GLEASON - Gleason Score (phv00396697.v2.p2)
STAGE - Stage of the disease (phv00396698.v2.p2)

ANALYTE_TYPE - Analyte type (phv00396701.v3.p2)
BODY_SITE - Body site where sample was collected (phv00396700.v3.p2)
CLINICAL_IMPORTANCE - Clinical importance (phv00529814.v1.p2)
CONSENT - Consent group as determined by DAC (phv00396684.v3.p2)
IS_TUMOR - Tumor status (phv00396702.v3.p2)
SAMPLE_ID - De-identified sample ID (phv00396699.v3.p2)
SAMPLE_ID - Sample ID (phv00396687.v3.p2)
STUDY - Study (phv00396691.v2.p2)
SUBJECT_ID - Subject ID (phv00396681.v3.p2)
SUBJECT_ID - De-identified subject ID (phv00396692.v2.p2)
SUBJECT_ID - Subject ID (phv00396686.v3.p2)
SUBJECT_SOURCE - Subject source (phv00396682.v3.p2)
SUBJECT_SOURCE_ID - Source subject ID (phv00494210.v2.p2)
SUBJECT_SOURCE_ID2 - Subject source ID 2 (phv00494212.v2.p2)
SUBJECT_SOURCE_ID3 - Subject source ID 3 (phv00540920.v1.p2)
SUBJECT_SOURCE_ID4 - Subject source ID 4 (phv00540922.v1.p2)
SUBJECT_SOURCE_ID5 - Subject source ID 5 (phv00540924.v1.p2)
SUBJECT_SOURCE2 - Subject source 2 (phv00494211.v2.p2)
SUBJECT_SOURCE3 - Subject source 3 (phv00540919.v1.p2)
SUBJECT_SOURCE4 - Subject source 4 (phv00540921.v1.p2)
SUBJECT_SOURCE5 - Subject source 5 (phv00540923.v1.p2)